Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
2.
Sci Eng Ethics ; 24(4): 1331-1338, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-28597218

RESUMEN

The trend of emerging biorefineries is to process the harvest as efficiently as possible and without any waste. From the most valuable phytomass, refined medicines, enzymes, dyes and other special reactants are created. Functional foods, food ingredients, oils, alcohol, solvents, plastics, fillers and a wide variety of other chemical products follow. After being treated with nutrient recovery techniques (for fertilizer production), biofuels or soil improvers are produced from the leftovers. Economic optimization algorithms have confirmed that such complex biorefineries can be financially viable only when a high degree of feedstock concentration is included. Because the plant material is extremely voluminous before processing, the farming intensity of special plants increases in the nearest vicinity of agglomerations where the biorefineries are built for logistical reasons. Interdisciplinary analyses revealed that these optimization measures lead to significantly increased pollen levels in neighbouring urban areas and subsequently an increased risk of allergies, respectively costs to the national health system. A new moral dilemma between the shareholder's profit and public interest was uncovered and subjected to disputation.


Asunto(s)
Biocombustibles , Exposición a Riesgos Ambientales/ética , Fertilizantes , Industrias/ética , Plantas , Polen/efectos adversos , Tecnología , Agricultura/economía , Agricultura/ética , Biomasa , Biotecnología , Análisis Costo-Beneficio , Atención a la Salud/economía , Exposición a Riesgos Ambientales/efectos adversos , Ética en los Negocios , Humanos , Hipersensibilidad/etiología , Industrias/economía , Principios Morales , Responsabilidad Social
4.
PLoS One ; 9(7): e101533, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24992571

RESUMEN

BACKGROUND: Dietary supplement use is increasing despite lack of evidence of benefits, or evidence of harm. Press releases issued by the supplements industry might contribute to this situation by using 'spin' (strategies to hype or denigrate findings) to distort the results of clinical studies. We assessed press releases issued in response to publication of clinical studies on dietary supplements. METHODS AND FINDINGS: We analyzed 47 supplements industry press releases and 91 non-industry press releases and news stories, generated in response to 46 clinical studies of dietary supplements published between 1/1/2005 and 5/31/2013. The primary outcome was 'spin' content and direction. We also assessed disposition towards use of dietary supplements, reporting of study information, and dissemination of industry press releases. More supplements industry press releases (100%) contained 'spin' than non-industry media documents (55%, P<0.001). Hyping 'spin' scores were higher in industry than non-industry media documents for studies reporting benefit of supplements (median 'spin' score 3.3, 95% CI 1.0-5.5 vs 0.5, 0-1.0; P<0.001). Denigratory 'spin' scores were higher in industry than non-industry media documents for studies reporting no effect (6.0, 5.0-7.0 vs 0, 0-0; P<0.001) or harm (6.0, 5.5-7.5 vs 0, 0-0.5; P<0.001) from a supplement. Industry press releases advocated supplement use in response to >90% of studies that reported no benefit, or harm, of the supplement. Industry press releases less frequently reported study outcomes, sample size, and estimates of effect size than non-industry media documents (all P<0.001), particularly for studies that reported no benefit of supplements. Industry press releases were referenced by 148 news stories on the websites of 6 organizations that inform manufacturers, retailers and consumers of supplements. CONCLUSIONS: Dietary supplements industry press releases issued in response to clinical research findings are characterized by 'spin' that hypes results that are favourable to supplement use and denigrates results that are not.


Asunto(s)
Industrias/ética , Difusión de la Información/ética , Edición , Investigación Biomédica , Estudios de Casos y Controles , Suplementos Dietéticos , Humanos , Internet , Medios de Comunicación de Masas
7.
Bus Ethics Q ; 12(4): 433-50, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12708455

RESUMEN

In this paper we highlight the emergence of organizational ethics issues in health care as an important outcome of the changing structure of health care delivery. We emphasize three core themes related to business ethics and health care ethics: integrity, responsibility, and choice. These themes are brought together in a discussion of the process of Mission Discernment as it has been developed and implemented within an integrated health care system. Through this discussion we highlight how processes of institutional reflection, such as Mission Discernment, can help health care organizations, as well as corporations, make critical choices in turbulent environments that further the core mission and values and fulfill institutional responsibilities to a broad range of stakeholders.


Asunto(s)
Prestación Integrada de Atención de Salud/ética , Atención a la Salud/organización & administración , Ética en los Negocios , Ética Institucional , Objetivos Organizacionales , Catolicismo , Atención a la Salud/ética , Atención a la Salud/tendencias , Prestación Integrada de Atención de Salud/economía , Emprendimiento , Teoría Ética , Hospitales Religiosos , Industrias/ética , Rol del Médico , Relaciones Médico-Paciente , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA